• Diagnosis​ ​Info​ ​and​ ​General​ ​Questions

  For DMD, Idebenone on Path to EMA Conditional Marketing Authorization

  Posted by MD forums Moderator on April 2, 2019 at 7:14 pm

  

  Reanthera Pharmaceuticals will file for a conditional marketing authorization with the EMA for idebenone to treat respiratory dysfunction in DMD patients. Click here to learn more.

  What are your thoughts on this news?

  replied 6 years, 6 months ago 1 Member · 0 Replies
• 0 Replies

Log In to Reply